Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | 12 | 0 | 0 | 0 | €21.91 | €60.13 | 174.418% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €152.18 | €174.43 | 14.623% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.75 | - | - |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €90.40 | - | - |
| Compugen Ltd. | 2 | 2 | 0 | 0 | €2.01 | €3.67 | 82.813% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €124.20 | €130.00 | 4.670% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.96 | - | - |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Adaptimmune Therapeutics PLC ADR | 2 | 0 | 2 | 0 | €1.12 | €1.70 | 51.786% |
| Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €4.12 | €10.96 | 165.916% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €141.60 | €228.30 | 61.229% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.34 | €20.00 | 9.051% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.05 | €28.06 | 86.426% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €44.27 | €70.00 | 58.121% |
| Eli Lilly Corp. | 51 | 0 | 5 | 0 | €683.50 | €759.34 | 11.095% |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €46.20 | - | - |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.94 | €8.39 | 332.948% |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.76 | - | - |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.50 | €73.92 | 6.360% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.75 | €65.00 | -2.622% |
| Emergent Biosolutions Inc. | 2 | 3 | 1 | 1 | €3.61 | €4.62 | 27.895% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €2.10 | €12.09 | 475.686% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €141.15 | €165.00 | 16.897% |